Novartis Aktie
105,65
EUR
-0,95
EUR
-0,89
%
98,88
CHF
+0,38
CHF
+0,39
%
Werbung
Novartis Aktie Analyse
| 03.03.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 02.03.15 | Novartis buy | UBS AG | |
| 20.02.15 | Novartis buy | Jefferies & Company Inc. | |
| 09.02.15 | Novartis buy | Citigroup Corp. | |
| 28.01.15 | Novartis neutral | Morgan Stanley | |
| 28.01.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 28.01.15 | Novartis Hold | Deutsche Bank AG | |
| 28.01.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
|
Werbung
|
|||
| 27.01.15 | Novartis Halten | Independent Research GmbH | |
| 26.01.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 23.01.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.01.15 | Novartis Outperform | BNP PARIBAS | |
| 22.01.15 | Novartis buy | UBS AG | |
| 21.01.15 | Novartis neutral | Morgan Stanley | |
| 21.01.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 20.01.15 | Novartis Equal-Weight | Morgan Stanley | |
| 20.01.15 | Novartis neutral | Independent Research GmbH | |
| 19.01.15 | Novartis buy | Kepler Cheuvreux | |
| 16.01.15 | Novartis buy | UBS AG | |
| 16.01.15 | Novartis buy | Jefferies & Company Inc. | |
| 16.01.15 | Novartis buy | S&P Capital IQ | |
| 16.01.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 15.01.15 | Novartis Hold | Deutsche Bank AG | |
| 05.01.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 15.12.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 12.12.14 | Novartis buy | UBS AG | |
| 09.12.14 | Novartis Neutral | Merrill Lynch & Co., Inc. | |
| 09.12.14 | Novartis Neutral | Merrill Lynch & Co., Inc. | |
| 03.12.14 | Novartis Equal-Weight | Morgan Stanley | |
| 28.11.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 25.11.14 | Novartis Outperform | BNP PARIBAS | |
| 13.11.14 | Novartis buy | UBS AG | |
| 10.11.14 | Novartis buy | Jefferies & Company Inc. | |
| 05.11.14 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 31.10.14 | Novartis Halten | Independent Research GmbH | |
| 29.10.14 | Novartis Hold | Deutsche Bank AG | |
| 28.10.14 | Novartis buy | S&P Capital IQ | |
| 23.10.14 | Novartis buy | UBS AG | |
| 16.10.14 | Novartis Equal weight | Barclays Capital | |
| 14.10.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 14.10.14 | Novartis Underweight | Morgan Stanley | |
| 08.10.14 | Novartis Hold | Deutsche Bank AG | |
| 19.09.14 | Novartis Hold | Deutsche Bank AG | |
| 16.09.14 | Novartis Underweight | Morgan Stanley | |
| 15.09.14 | Novartis buy | Jefferies & Company Inc. | |
| 11.09.14 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.09.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 04.09.14 | Novartis Outperform | BNP PARIBAS | |
| 03.09.14 | Novartis Halten | Independent Research GmbH | |
| 02.09.14 | Novartis overweight | JP Morgan Chase & Co. | |
Werbung
Werbung